跳转至内容
Merck

927732

Sigma-Aldrich

C5 Lenalidomide-difluoroPEG1-C4-piperazine Hydrochloride

≥95%

别名:

2-(2,2-Difluoro-3-(4-(piperazin-1-yl)butoxy)propoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)acetamide Hydrochloride

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C26H35F2N5O6 · xHCl
分子量:
551.58 (free base basis)
MDL號碼:
分類程式碼代碼:
12352200
NACRES:
NA.22

ligand

C5 Lenalidomide

品質等級

化驗

≥95%

形狀

powder

儲存溫度

2-8°C

SMILES 字串

O=C1N(C2CCC(NC2=O)=O)CC3=CC(NC(COCC(F)(F)COCCCCN4CCNCC4)=O)=CC=C31.Cl

InChI

1S/C26H35F2N5O6.ClH/c27-26(28,16-38-12-2-1-9-32-10-7-29-8-11-32)17-39-15-23(35)30-19-3-4-20-18(13-19)14-33(25(20)37)21-5-6-22(34)31-24(21)36;/h3-4,13,21,29H,1-2,5-12,14-17H2,(H,30,35)(H,31,34,36);1H

InChI 密鑰

NWCOGWMYGNQKPZ-UHFFFAOYSA-N

應用

Protein degrader building block C5 Lenalidomide-difluoroPEG1-C4-piperazine Hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand, a fluorinated linker with both hydrophobic and hydrophilic moieties, and a pendant amine for reactivity with a carboxylic acid on the target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant amine, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.


Targeted Protein Degradation

象形圖

Health hazard

訊號詞

Warning

危險聲明

危險分類

Repr. 2 - STOT RE 2

標靶器官

Blood

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Daniel P Bondeson et al.
Annual review of pharmacology and toxicology, 57, 107-123 (2016-10-13)
Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门